Molecular Templates Inc logo

MTEM

Molecular Templates Inc

$0.87

Earnings Summary

Revenue
$8.49Mn
Net Profits
$-21.61Mn
Net Profit Margins
-254.67%

Highlights

Revenue:

Molecular Templates Inc’s revenue jumped 163.54% since last year same period to $8.49Mn in the Q1 2022. On a quarterly growth basis, Molecular Templates Inc has generated -52.76% fall in its revenue since last 3-months.

Net Profits:

Molecular Templates Inc’s net profit jumped 19.3% since last year same period to $-21.61Mn in the Q1 2022. On a quarterly growth basis, Molecular Templates Inc has generated -110.98% fall in its net profits since last 3-months.

Net Profit Margins:

Molecular Templates Inc’s net profit margin jumped 69.38% since last year same period to -254.67% in the Q1 2022. On a quarterly growth basis, Molecular Templates Inc has generated -346.63% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Molecular Templates Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.48
EPS Estimate Current Year
-0.48

Highlights

EPS Estimate Current Quarter:

Molecular Templates Inc’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a -2.13% fall from last quarter’s estimates.

EPS Estimate Current Year:

Molecular Templates Inc’s earning per share (EPS) estimates for the current year stand at -0.48.

Key Ratios

Key ratios of the Molecular Templates Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.38
Return on Assets (ROA)
-0.27
Return on Equity (ROE)
-1.4
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Molecular Templates Inc’s earning per share (EPS) jumped 25.49% since last year same period to -0.38 in the Q1 2022. This indicates that the Molecular Templates Inc has generated 25.49% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Molecular Templates Inc’s return on assets (ROA) stands at -0.27.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Molecular Templates Inc’s return on equity (ROE) stands at -1.4.

Dividend Per Share (DPS):

Molecular Templates Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-13
-0.47
-0.38
19.15%

Company Information

Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Its proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Organisation
Molecular Templates Inc
Headquarters
Austin, Texas, US
Employees
239
Industry
Health Technology
CEO
Harold Selick